HORMONAL IUD (LNG) BIBLIOGRAPHY

1. New contraceptive launched. Fam Plann Today. 1995:1.
Link to PubMed

2. Mirena intrauterine system seeks U.S. nod. Contracept Technol Update. Apr 2000;21(4):44-45.
Link to PubMed

3. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception. Jan 1994;49(1):56-72.
Link to PubMed

4. Arias RD. Compelling reasons for recommending IUDs to any woman of reproductive age. Int J Fertil Womens Med. Mar-Apr 2002;47(2):87-95.
Link to PubMed

5. Backman T, Rauramo I, Jaakkola K, et al. Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol. Oct 2005;106(4):813-817.
Link to PubMed

6. Backman T, Huhtala S, Luoto R, Tuominen J, Rauramo I, Koskenvuo M. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol. Apr 2002;99(4):608-613.
Link to PubMed

7. Bahamondes L, Hidalgo M, Petta CA, Diaz J, Espejo-Arce X, Monteiro-Dantas C. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant. J Reprod Med. Aug 2003;48(8):637-640.
Link to PubMed

8. Bahamondes L, Ribeiro-Huguet P, de Andrade KC, Leon-Martins O, Petta CA. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Acta Obstet Gynecol Scand. Jun 2003;82(6):580-582.
Link to PubMed

9. Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception. Feb 2003;67(2):87-91.
Link to PubMed

10. Batur P, Elder J, Mayer M. Update on contraception: benefits and risks of the new formulations. Cleve Clin J Med. Aug 2003;70(8):681-682, 685-686, 668-690 passim.
Link to PubMed

11. Cheng L, Gulmezoglu AM, Oel CJ, Piaggio G, Ezcurra E, Look PF. Interventions for emergency contraception. Cochrane Database Syst Rev. 2004(3):CD001324.
Link to PubMed

12. Chi IC. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Contraception. Dec 1991;44(6):573-588.
Link to PubMed

13. Chiou CF, Trussell J, Reyes E, et al. Economic analysis of contraceptives for women. Contraception. Jul 2003;68(1):3-10.
Link to PubMed

14. Cooling H. Successful use of levonorgestrel intrauterine system in a HIV positive woman. Br J Fam Plann. Apr 1999;25(1):25-26.
Link to PubMed

15. Diaz J, Bahamondes L, Monteiro I, Petta C, Hildalgo MM, Arce XE. Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. Contraception. Aug 2000;62(2):59-61.
Link to PubMed

16. Dhar KK, NeedhiRajan T, Koslowski M, Woolas RP. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol. Jun 2005;97(3):924-927.
Link to PubMed

17. Fortney JA, Feldblum PJ, Raymond EG. Intrauterine devices. The optimal long-term contraceptive method? J Reprod Med. Mar 1999;44(3):269-274.
Link to PubMed

18. Freeman S. Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling. J Am Acad Nurse Pract. Jun 2004;16(6):226-238.
Link to PubMed

19. French RS, Cowan FM, Mansour D, et al. Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. Bjog. Oct 2000;107(10):1218-1225.
Link to PubMed

20. Giannopoulos T, Butler-Manuel S, Tailor A. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecol Oncol. Dec 2004;95(3):762-764.
Link to PubMed

21. Grimes. IN Hatcher R. Contraceptive Technology. 18th ed. New York: Ardent Media; 2004.
(no link available)

22. Grimes D, Schulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev. 2004(4):CD001777.
Link to PubMed

23. Haimov-Kochman R, Amsalem H, Adoni A, Lavy Y, Spitz IM. Management of a perforated levonorgestrel-medicated intrauterine device--a pharmacokinetic study: case report. Hum Reprod. Jun 2003;18(6):1231-1233.
Link to PDF

24. Haimov-Kochman R, Doviner V, Amsalem H, Prus D, Adoni A, Lavy Y. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation. Hum Reprod. May 2003;18(5):990-993.
Link to PDF

25. Hamill M, Bowling J, Vega-Lopez F. Sweet's syndrome and a Mirena intrauterine system. J Fam Plann Reprod Health Care. Apr 2004;30(2):115-116.
Link to PubMed

26. Hassan MA, Killick SR. Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity? Hum Reprod. Feb 2004;19(2):344-351.
Link to PubMed

27. Herndon EJ, Zieman M. New contraceptive options. Am Fam Physician. Feb 15 2004;69(4):853-860.
Link to Full Text

28. Kailasam C, Akande V, Gordon UD. Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report. J Assist Reprod Genet. Mar 2005;22(3):137-140.
Link to PubMed

29. Kaunitz AM. Long-acting contraceptive options. Int J Fertil Menopausal Stud. Mar-Apr 1996;41(2):69-76.
Link to PubMed

30. Khawaja N, Walsh T, Donovan M, McKenna P, Geary M. The Mirena Intrauterine System--reliable contraception for the 21st century. Ir Med J. Sep 2004;97(8):229.
Link to PubMed

31. Kwong FN, Rai H, Mayne C. Ectopic pregnancy with a translocated Mirena intrauterine system. J Fam Plann Reprod Health Care. Apr 2002;28(2):95-96.
Link to PubMed

32. Maia H, Jr., Maltez A, Coelho G, Athayde C, Coutinho EM. Insertion of mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc. Nov 2003;10(4):512-516.
Link to PubMed

33. McGavigan CJ, Cameron IT. The Mirena levonorgestrel system. Drugs Today (Barc). Dec 2003;39(12):973-984.
Link to PubMed

34. Mercorio F, De Simone R, Di Spiezio Sardo A, et al. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. Contraception. Apr 2003;67(4):277-280.
Link to PubMed

35. Monteiro I, Bahamondes L, Diaz J, Perrotti M, Petta C. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1). Contraception. May 2002;65(5):325-328.
Link to PubMed

36. Nilsson CG, Luukkainen T, Diaz J, Allonen H. Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device. Contraception. Apr 1982;25(4):345-356.
Link to PubMed

37. Nitke S, Rabinerson D, Dekel A, Sheiner E, Kaplan B, Hackmon R. Lost levonorgestrel IUD: diagnosis and therapy. Contraception. Apr 2004;69(4):289-293.
Link to PubMed

38. Pakarinen P, Toivonen J, Luukkainen T. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up. Contraception. Jul 2003;68(1):31-34.
Link to PubMed

39. Penney G, Brechin S, Allerton L. FFPRHC Guidance (July 2005): The use of contraception outside the terms of the product licence. J Fam Plann Reprod Health Care. Jul 2005;31(3):225-241; quiz 242.
Link to PubMed

40. Phillips V, Graham CT, Manek S, McCluggage WG. The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J Clin Pathol. Apr 2003;56(4):305-307.
Link to Article

41. Robinson GE. Contraception in the latter part of reproductive life. Contemp Rev Obstet Gynaecol. Oct 1992;4(4):223-226.
Link to PubMed

42. Rogovskaya S, Rivera R, Grimes DA, et al. Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial. Obstet Gynecol. Apr 2005;105(4):811-815.
Link to PubMed

43. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand. Sep 1999;78(8):716-721.
Link to PubMed

44. Sivin I, Stern J, Coutinho E, et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Contraception. Nov 1991;44(5):473-480.
Link to PubMed

45. Soysal S, Soysal ME. The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial. Gynecol Obstet Invest. 2005;59(1):29-35.
Link to PubMed

46. Sturridge F, Guillebaud J. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system. Drug Saf. Dec 1996;15(6):430-440.
Link to PubMed

47. Suvisaari J, Lahteenmaki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception. Oct 1996;54(4):201-208.
Link to PubMed

48. Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception. Jul 2001;64(1):33-37.
Link to PubMed

49. Varney SJ, Guest JF. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK. Pharmacoeconomics. 2004;22(17):1141-1151.
Link to PubMed

50. Veldhuis HM, Vos AG, Lagro-Janssen AL. Complications of the intrauterine device in nulliparous and parous women. Eur J Gen Pract. Sep 2004;10(3):82-87.
Link to PubMed

51. Vercellini P, Frontino G, De Giorgi O, Aimi G, Zaina B, Crosignani PG. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril. Aug 2003;80(2):305-309.
Link to PubMed

52. Zalel Y, Gamzu R, Shulman A, Achiron R, Schiff G, Lidor A. The progestative effect of the levonorgestrel-releasing intrauterine system--when does it manifest? Contraception. Jun 2003;67(6):473-476.
Link to PubMed

53. Zalel Y, Shulman A, Lidor A, Achiron R, Mashiach S, Gamzu R. The local progestational effect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study. Hum Reprod. Nov 2002;17(11):2878-2880.
Link to PDF